Human PAF complexes in endocrine tumors and pancreatic cancer

References

• Moniaux N, Nemos C, Schmied BM et al. The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis. Oncogene25, 3247–3257 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang C, Kong D, Tan MH et al. Parafibromin inhibits cancer cell growth and causes G1 phase arrest. Biochem. Biophys. Res. Commun.350, 17–24 (2006).
   PubMed Web of Science ®Google Scholar
• Krogan NJ, Kim M, Ahn SH et al. RNA polymerase II elongation factors of Saccharomyces cerevisiae: a targeted proteomics approach. Mol. Cell. Biol.22, 6979–6992 (2002).
   PubMed Web of Science ®Google Scholar
• Pavri R, Zhu B, Li G et al. Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II. Cell19(125), 703–717 (2006).
   Web of Science ®Google Scholar
• Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ et al. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol. Cell. Biol.25, 612–620 (2005).
   PubMed Web of Science ®Google Scholar
• Cheng JQ, Ruggeri B, Klein WM et al. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl Acad. Sci. USA93, 3636–3641 (1996).
   PubMed Web of Science ®Google Scholar
• Woodard GE, Lin L, Zhang JH et al. Parafibromin, product of the hyperparathyroidism–jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene24, 1272–1276 (2005).
   PubMed Web of Science ®Google Scholar
• Bradley KJ, Bowl MR, Williams SE et al. Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal. Oncogene26, 1213–1221 (2007).
   PubMed Web of Science ®Google Scholar
• Parada LA, Hallen M, Tranberg KG et al. Frequent rearrangements of chromosomes 1, 7, and 8 in primary liver cancer. Genes Chromosomes Cancer23, 26–35 (1998).
   PubMed Web of Science ®Google Scholar
• Stange DE, Radlwimmer B, Schubert F et al. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer. Clin.Cancer Res.12, 345–352 (2006).
   PubMed Web of Science ®Google Scholar
• Selvarajan S, Sii LH, Lee A et al. Parafibromin expression in breast cancer: a novel marker for prognostication? J. Clin. Pathol.61, 64–67 (2008).
   PubMed Web of Science ®Google Scholar
• Korshunov A, Sycheva R, Gorelyshev S et al. Clinical utility of fluorescence in situ hybridization (FISH) in nonbrainstem glioblastomas of childhood. Mod. Pathol.18, 1258–1263 (2005).
   PubMed Web of Science ®Google Scholar
• Chang MC, Chang YT, Tien YW et al. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization. Oncol. Rep.14, 867–872 (2005).
   PubMed Web of Science ®Google Scholar
• Mosimann C, Hausmann G, Basler K. Parafibromin/hyrax activates wnt/wg target gene transcription by direct association with b-catenin/armadillo. Cell125, 327–341 (2006).
   PubMed Web of Science ®Google Scholar
• Camps J, Armengol G, del Rey J et al. Genome-wide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis27, 419–428 (2006).
   PubMed Web of Science ®Google Scholar
• Tarkkanen M, Larramendy ML, Bohling T et al. Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistry. Eur. J. Cancer42(8), 1172–1180 (2006).
   PubMed Web of Science ®Google Scholar
• Nathrath MH, Kuosaite V, Rosemann M et al. Two novel tumor suppressor gene loci on chromosome 6q and 15q in human osteosarcoma identified through comparative study of allelic imbalances in mouse and man. Oncogene21, 5975–5980 (2002).
   PubMed Web of Science ®Google Scholar
• Redeker E, Alders M, Hoovers JM et al. Physical mapping of 3 candidate tumor suppressor genes relative to Beckwith–Wiedemann syndrome associated chromosomal breakpoints at 11p15.3. Cytogenet. Cell Genet.68, 222–225 (1995).
   PubMedGoogle Scholar
• Bashyam MD, Bair R, Kim YH et al. Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia7, 556–562 (2005).
   PubMed Web of Science ®Google Scholar
• Zhu B, Mandal SS, Pham AD et al. The human PAF complex coordinates transcription with events downstream of RNA synthesis. Genes Dev.19, 1668–1673 (2005).
   PubMed Web of Science ®Google Scholar
• Chaudhary K, Deb S, Moniaux N et al. Human RNA polymerase II-associated factor complex: dysregulation in cancer. Oncogene26, 7499–7507 (2007).
   PubMed Web of Science ®Google Scholar
• Birkenkamp-Demtroder K, Christensen LL, Olesen SH et al. Gene expression in colorectal cancer. Cancer Res.62, 4352–4363 (2002).
   PubMed Web of Science ®Google Scholar
• Mao X, Lillington D, Child F et al. Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis. Genes Chromosomes. Cancer35, 144–155 (2002).
   PubMed Web of Science ®Google Scholar
• Risbridger GP, Schmitt JF, Robertson DM. Activins and inhibins in endocrine and other tumors. Endocr. Rev.22, 836–858 (2001).
   PubMed Web of Science ®Google Scholar
• Grimelius L, Johansson H. Pathology of parathyroid tumors. Semin. Surg. Oncol.13, 142–154 (1997).
   Google Scholar
• Iacobone M, Lumachi F, Favia G. Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases. J. Surg.Oncol.88, 223–228 (2004).
   PubMed Web of Science ®Google Scholar
• Bradley KJ, Hobbs MR, Buley ID et al. Uterine tumours are a phenotypic manifestation of the hyperparathyroidism–jaw tumour syndrome. J. Intern. Med.257, 18–26 (2005).
   PubMed Web of Science ®Google Scholar
• Howell VM, Haven CJ, Kahnoski K et al.HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J. Med. Genet.40, 657–663 (2003).
   PubMed Web of Science ®Google Scholar
• Shattuck TM, Valimaki S, Obara T et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.N. Engl. J. Med.349, 1722–1729 (2003).
   PubMed Web of Science ®Google Scholar
• Wang P, Bowl MR, Bender S et al. Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice. Mol. Cell. Biol.28, 2930–2940 (2008).
   PubMed Web of Science ®Google Scholar
• Murre C, McCaw PS, Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell56, 777–783 (1989).
   PubMed Web of Science ®Google Scholar
• Perry RR, Vinik AI. Endocrine tumors of the gastrointestinal tract. Annu. Rev. Med.47, 57–68 (1996).
   PubMed Web of Science ®Google Scholar
• Stabile BE, Morrow DJ, Passaro E Jr. The gastrinoma triangle: operative implications. Am. J. Surg.147, 25–31 (1984).
   PubMed Web of Science ®Google Scholar
• Curtis LJ, Li Y, Gerbault-Seureau M et al. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines. Genomics53, 42 –55 (1998).
   PubMed Web of Science ®Google Scholar
• Schleger C, Arens N, Zentgraf H et al. Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH). J. Pathol.191, 27–32 (2000).
   PubMed Web of Science ®Google Scholar
• Bepler G, Koehler A. Multiple chromosomal aberrations and 11p allelotyping in lung cancer cell lines. Cancer Genet. Cytogenet.84, 39–45 (1995).
   PubMedGoogle Scholar
• Armengol G, Knuutila S, Lluis F et al. DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma. Cancer Genet. Cytogenet.116, 133–141 (2000).
   PubMedGoogle Scholar
• Breedlove G, Busenhart C. Screening and detection of ovarian cancer. J. Midwifery Womens Health50, 51–54 (2005).
   PubMed Web of Science ®Google Scholar
• Hightower RD, Nguyen HN, Averette HE et al. National survey of ovarian carcinoma. IV: patterns of care and related survival for older patients. Cancer73, 377–383 (1994).
   PubMed Web of Science ®Google Scholar
• de la CR, Maestro ML, Solana J et al. Tissue quantification of CA 125 in epithelial ovarian cancer. Int. J. Biol. Markers14, 106–114 (1999).
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E et al. Cancer statistics, 2007. CA Cancer J. Clin.57, 43–66 (2007).
   PubMed Web of Science ®Google Scholar
• Thompson FH, Nelson MA, Trent JM et al. Amplification of 19q13.1–q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies. Cancer Genet. Cytogenet.87, 55–62 (1996).
   PubMed Web of Science ®Google Scholar
• Guan XY, Cargile CB, Anzick SL et al. Chromosome microdissection identifies cryptic sites of DNA sequence amplification in human ovarian carcinoma. Cancer Res.55, 3380–3385 (1995).
   PubMed Web of Science ®Google Scholar
• Panani AD, Roussos C. Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality. Cancer Lett.235, 130–135 (2006).
   PubMed Web of Science ®Google Scholar
• Panani AD. Preferential involvement of chromosome 11 as add(11)(p15) in ovarian cancer: is it a common cytogenetic abnormality in cancer? Cancer Lett.258, 262–267 (2007).
   PubMed Web of Science ®Google Scholar
• Cavalli LR, Urban CA, Dai D et al. Genetic and epigenetic alterations in sentinel lymph nodes metastatic lesions compared with their corresponding primary breast tumors. Cancer Genet.Cytogenet.146, 33–40 (2003).
   PubMedGoogle Scholar
• Batra SK, Metzgar RS, Hollingsworth MA. Molecular cloning and sequence analysis of the human ribosomal protein S16. J. Biol. Chem.266, 6830–6838 (1991).
   PubMedGoogle Scholar
• Heidenblad M, Lindgren D, Veltman JA et al. Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications. Oncogene24, 1794–1801 (2005).
   PubMed Web of Science ®Google Scholar
• Mahlamaki EH, Kauraniemi P, Monni O et al. High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer. Neoplasia6, 432–439 (2004).
   PubMed Web of Science ®Google Scholar
• Carpten JD, Robbins CM, Villablanca A et al.HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome. Nat. Genet.32, 676–680 (2002).
   PubMed Web of Science ®Google Scholar
• Lin L, Czapiga M, Nini L et al. Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism–jaw tumor syndrome enhances its proapoptotic function. Mol. Cancer Res.5, 183–193 (2007).
   PubMed Web of Science ®Google Scholar
• Bradley KJ, Cavaco BM, Bowl MR et al. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clin. Endocrinol. (Oxf.)64, 299–306 (2006).
   PubMed Web of Science ®Google Scholar